EGCG Blocked Phenylephrin-Induced Hypertrophy in H9C2 Cardiomyocytes, by Activating AMPK-Dependent Pathway

다국어 초록 (Multilingual Abstract)

AMP-activated protein kinase (AMPK) is a key regulator of energy metabolism. Previous studies have shown that activation of AMPK results in suppression of cardiac myocyte hypertrophy via inhibition of the p70S6 kinase (p70S6K) and eukaryotic elongation factor-2 (eEF2) signaling pathways.
Epigallocatechin-3-gallate (EGCG), the major polyphenol found in green tea, possesses multiple protective effects on the cardiovascular system including cardiac hypertrophy. However, the molecular mechanisms has not been well investigated. In this study, we found that EGCG could significantly reduce natriuretic peptides type A (Nppa), brain natriuretic polypeptide (BNP) mRNA expression and decrease cell surface area in H9C2 cardiomyocytes stimulated with phenylephrine (PE). Moreover, we showed that AMPK is activated in H9C2 cardiomyocytes by EGCG, and AMPK-dependent pathway participates in the inhibitory effects of EGCG on cardiac hypertrophy. Taken together, our findings provide the first evidence that the effect of EGCG against cardiac hypertrophy may be attributed to its activation on AMPK-dependent signaling pathway, suggesting the therapeutic potential of EGCG on the prevention of cardiac remodeling in patients with pressure overload hypertrophy.

참고문헌 (Reference)

1 Qiao W, "The histone acetyltransferase MOF overexpression blunts cardiac hypertrophy by targeting ROS in mice" 448 : 379-384, 2014

2 박소연, "The Stimulatory Effect of Essential Fatty Acids on Glucose Uptake Involves Both Akt and AMPK Activation in C2C12 Skeletal Muscle Cells" 대한약리학회 18 (18): 255-261, 2014

3 Mudd JO, "Tackling heart failure in the twenty-first century" 451 : 919-928, 2008

4 Sandström ME, "Role of reactive oxygen species in contraction-mediated glucose transport in mouse skeletal muscle" 575 : 251-262, 2006

5 Thandapilly SJ, "Resveratrol prevents norepinephrine induced hypertrophy in adult rat cardiomyocytes, by activating NO-AMPK pathway" 668 : 217-224, 2011

6 Chan AY, "Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt" 283 : 24194-24201, 2008

7 Kang S, "Resistin promotes cardiac hypertrophy via the AMP-activated protein kinase/mammalian target of rapamycin (AMPK/mTOR) and c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathways" 286 : 18465-18473, 2011

8 Pillai VB, "Regulation of Akt signaling by sirtuins: its implication in cardiac hypertrophy and aging" 114 : 368-378, 2014

9 Choi HC, "Reactive nitrogen species is required for the activation of the AMP-activated protein kinase by statin in vivo" 283 : 20186-20197, 2008

10 Shioi T, "Rapamycin attenuates load-induced cardiac hypertrophy in mice" 107 : 1664-1670, 2003

11 김수정, "Neuroprotective Effects of AMP-Activated Protein Kinase on Scopolamine Induced Memory Impairment" 대한약리학회 17 (17): 331-338, 2013

12 Valenti D, "Negative modulation of mitochondrial oxidative phosphorylation by epigallocatechin-3 gallate leads to growth arrest and apoptosis in human malignant pleural mesothelioma cells" 1832 : 2085-2096, 2013

13 Zhuo L, "NAD blocks high glucose induced mesangial hypertrophy via activation of the sirtuins-AMPK-mTOR pathway" 27 : 681-690, 2011

14 차혜나, "Metformin Inhibits Isoproterenol-induced Cardiac Hypertrophy in Mice" 대한약리학회 14 (14): 377-384, 2010

15 Nolin TD, "Mechanisms of drug-induced nephrotoxicity" (196) : 111-130, 2010

16 Cai Y, "Green tea epigallocatechin-3-gallate attenuates Porphyromonas gingivalis-induced atherosclerosis" 67 : 76-83, 2013

17 김석, "Exendin-4 Improves Nonalcoholic Fatty Liver Disease by Regulating Glucose Transporter 4 Expression in ob/ob Mice" 대한약리학회 18 (18): 333-339, 2014

18 Li HL, "Epigallocathechin-3 gallate inhibits cardiac hypertrophy through blocking reactive oxidative species-dependent and -independent signal pathways" 40 : 1756-1775, 2006

19 Zhou J, "Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, stimulates hepatic autophagy and lipid clearance" 9 : e87161-, 2014

20 Wolfram S, "Effects of green tea and EGCG on cardiovascular and metabolic health" 26 : 373S-388S, 2007

21 Priyadarshi S, "Effect of green tea extract on cardiac hypertrophy following 5/6 nephrectomy in the rat" 63 : 1785-1790, 2003

22 Cai Y, "EGCG inhibits CTGF expression via blocking NF-κB activation in cardiac fibroblast" 20 : 106-113, 2013

23 Hernández JS, "Crosstalk between AMPK activation and angiotensin II-induced hypertrophy in cardiomyocytes: the role of mitochondria" 18 : 709-720, 2014

24 Murase T, "Catechin-induced activation of the LKB1/AMP-activated protein kinase pathway" 78 : 78-84, 2009

25 Messerli FH, "Cardioprotection with beta-blockers: myths, facts and Pascal's wager" 266 : 232-241, 2009

26 Hwang JT, "Apoptotic effect of EGCG in HT-29 colon cancer cells via AMPK signal pathway" 247 : 115-121, 2007

27 Zhong Y, "Anti-inflammatory activity of lipophilic epigallocatechin gallate (EGCG) derivatives in LPS-stimulated murine macrophages" 134 : 742-748, 2012

28 Oka T, "Angiogenesis and cardiac hypertrophy : maintenance of cardiac function and causative roles in heart failure" 114 : 565-571, 2014

29 Go AS, "American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics--2014 update: a report from the American Heart Association" 129 : e28-e292, 2014

30 Zou MH, "Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen species" 279 : 43940-43951, 2004

31 Chan AY, "Activation of AMP-activated protein kinase inhibits protein synthesis associated with hypertrophy in the cardiac myocyte" 279 : 32771-32779, 2004

32 Beauloye C, "AMsPK activation, a preventive therapeutic target in the transition from cardiac injury to heart failure" 90 : 224-233, 2011

33 Zarrinpashneh E, "AMPKalpha2 counteracts the development of cardiac hypertrophy induced by isoproterenol" 376 : 677-681, 2008

34 Hardie DG, "AMPK: regulating energy balance at the cellular and whole body levels" 29 : 99-107, 2014

35 Zhang P, "AMP activated protein kinase-alpha2 deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction in mice" 52 : 918-924, 2008